Lexicon Pharmaceuticals (LXRX) Debt to Equity (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Debt to Equity of $0.24 for Q1 2026, down 70.08% year-over-year from $0.82 in Q1 2025, and down 51.23% quarter-over-quarter from $0.5 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Debt to Equity (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 17 years of Debt to Equity data on file, last reported at $0.24 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.24, down 70.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.24 (down 70.08% YoY), and the FY2025 annual result was $0.5, down 26.93% from the prior year.
- Debt to Equity retreated to $0.24 in Q1 2026 per LXRX's latest filing, from $0.5 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.07 in Q4 2023 and troughed at $0.17 in Q3 2022.
- A 5-year average of $0.5 and a median of $0.47 in 2025 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2023 and 2026: Debt to Equity jumped 330.85% in 2023, then tumbled 70.08% in 2026.
- A 5-year view of Debt to Equity shows it stood at $0.41 in 2022, then jumped by 157.67% to $1.07 in 2023, then slumped by 35.7% to $0.69 in 2024, then declined by 26.93% to $0.5 in 2025, then tumbled by 51.23% to $0.24 in 2026.
- Business Quant data shows LXRX's Debt to Equity at $0.24 in Q1 2026, $0.5 in Q4 2025, and $0.47 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | 0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.24 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.47 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.82 |
| Dec 31, 2024 | 0.69 |
| Sep 30, 2024 | 0.56 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.35 |
| Dec 31, 2023 | 1.07 |
| Sep 30, 2023 | 0.71 |
| Jun 30, 2023 | 0.53 |
| Mar 31, 2023 | 0.55 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.17 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.25 |
| Sep 30, 2021 | 0.09 |
| Jun 30, 2021 | 0.09 |
| Mar 31, 2021 | 0.08 |